Market Overview

UPDATE: Sterne Agee Downgrades Vitamin Shoppe on Slowed Traffic/NSP

Related VSI
Goldman Sachs Upgrades GNC, Cuts Vitamin Shoppe
Benzinga's Top Downgrades

In a report published Friday, Sterne Agee analyst Charles Grom downgraded the rating on Vitamin Shoppe (NYSE: VSI) from Buy to Neutral, and lowered the price target from $54.00 to $45.00.

In the report, Sterne Agee noted, “Once a model of consistency, something seems off with the VSI model as traffic has stalled and NSP has slowed considerably. While this isn't necessarily new news today, we don't have firm answers to many questions and with 1) a fickle consumer, 2) competitive pressures augmenting, and 3) peak EBIT, we can't identify a catalyst NT to jump-start VSI. Also, after scrubbing our model, the Street looks too high, so we adjust our EPS accordingly. Net, move to Neutral/PT to $45 from $54.”

Vitamin Shoppe closed on Thursday at $41.96.

Latest Ratings for VSI

DateFirmActionFromTo
Nov 2014Goldman SachsDowngradesBuyNeutral
Nov 2014Sterne AgeeDowngradesBuyNeutral
Nov 2014Deutsche BankDowngradesBuyHold

View More Analyst Ratings for VSI
View the Latest Analyst Ratings

Posted-In: Charles Grom Sterne AgeeAnalyst Color Downgrades Analyst Ratings

 

Related Articles (VSI)

Around the Web, We're Loving...

Get Benzinga's Newsletters